Jul 7, 2020

Mary Millard, Infection Prevention Advocate, became a patient advocate after suffering acute septic shock from a hospital procedure where she was infected with pseudomonas, a very powerful Gram negative bug, a bacteria that remains in her body. Mary talks about why she is intent on educating healthcare providers about...

Jul 7, 2020

Mary Millard, Infection Prevention Advocate, became a patient advocate after suffering acute septic shock from a hospital procedure where she was infected with pseudomonas, a very powerful Gram negative bug, a bacteria that remains in her body. Mary talks about why she is intent on educating healthcare providers about...

Jul 6, 2020

Michele Dilizia, Executive Director of Regulatory Affairs and Microbiology, Recce Pharmaceuticals discusses why Recce is focused on developing a new class of broad spectrum synthetic polymer-antibiotics that can be used repeatedly against a wide range of bacteria without contributing to antibiotic resistance.  Michele...

Jul 6, 2020

Michele Dilizia, Executive Director of Regulatory Affairs and Microbiology, Recce Pharmaceuticals discusses why Recce is focused on developing a new class of broad spectrum synthetic polymer-antibiotics that can be used repeatedly against a wide range of bacteria without contributing to antibiotic resistance.  Michele...

May 26, 2020

Jeff Stein, President and CEO, Cidara Therapeutics talks about  their antifungal platform rezafungin now in Phase 3 clinical development to address the needs of the vulnerable population of patients hospitalized for something else who get a life-threatening fungal infection in the hospital. Jeff also explains their...